Source:http://linkedlifedata.com/resource/pubmed/id/19112833
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
147
|
pubmed:dateCreated |
2008-12-30
|
pubmed:abstractText |
Cardiovascular disease is the most common cause of a high morbidity and mortality in patients on renal replacement therapy and is responsible for about 50% of deaths. Hypertension is the main risk factor for cardiovascular events in the general population as well as in haemodialysed (HD) patients. The hypertension in HD patients is caused by excess extracellular fluid volume (ECV) on the other hand hypertension resistant to normalization of ECV may result from the accelerated activity of the systemic and local--vascular renin-angiotensin-aldosteron system (RAAS). RAAS genes are potential etiological candidates for cardiovascular damage. The aim of the study was to evaluate the prevalence of hypertension, left ventricular hypertrophy, hypertensive retinopathy in patients treated with haemodialysis and to evaluate the association between the polymorphism of RAAS genes: ACE I/D, AGT M235T AT1R A1166C, CYP112 (-344) and the systemic complications of arterial hypertension such as hypertensive retinopathy, left ventricular hypertrophy and also mortality in haemodialysis patients.
|
pubmed:language |
pol
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/ACAT1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/ACE protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Acetyl-CoA C-Acetyltransferase,
http://linkedlifedata.com/resource/pubmed/chemical/Peptidyl-Dipeptidase A
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
1426-9686
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
209-16
|
pubmed:dateRevised |
2011-7-1
|
pubmed:meshHeading |
pubmed-meshheading:19112833-Acetyl-CoA C-Acetyltransferase,
pubmed-meshheading:19112833-Adult,
pubmed-meshheading:19112833-Aged,
pubmed-meshheading:19112833-Aged, 80 and over,
pubmed-meshheading:19112833-Causality,
pubmed-meshheading:19112833-Comorbidity,
pubmed-meshheading:19112833-Female,
pubmed-meshheading:19112833-Humans,
pubmed-meshheading:19112833-Hypertension, Renal,
pubmed-meshheading:19112833-Hypertrophy, Left Ventricular,
pubmed-meshheading:19112833-Male,
pubmed-meshheading:19112833-Middle Aged,
pubmed-meshheading:19112833-Peptidyl-Dipeptidase A,
pubmed-meshheading:19112833-Polymorphism, Genetic,
pubmed-meshheading:19112833-Prevalence,
pubmed-meshheading:19112833-Renal Dialysis,
pubmed-meshheading:19112833-Retinal Diseases,
pubmed-meshheading:19112833-Survival Rate
|
pubmed:year |
2008
|
pubmed:articleTitle |
[Genetic predisposition to systemic complications of arterial hypertension in maintenance haemodialysis patients].
|
pubmed:affiliation |
Klinika Nefrologii, Transplantologii i Chorób Wewnetrznych. bbzoma@mp.pl
|
pubmed:publicationType |
Journal Article,
English Abstract
|